Lucem Health and iRhythm Announce Strategic Partnership for Early Arrhythmia Detection
Lucem Health is pleased to announce a new strategic partnership with iRhythm Technologies, Inc. This alliance is a significant milestone in our ongoing efforts to harness the power of artificial intelligence in the service of earlier and more accurate disease detection. Through this collaboration, we align the analytics capabilities of Lucem Health’s Reveal for Arrhythmias with iRhythm’s proven Zio® ECG technology, creating a seamless solution designed to shift cardiac care from reactive diagnosis to predictive, data-driven intervention.
The Imperative for Predictive AI in Cardiovascular Care
Cardiac arrhythmias continue to affect millions of individuals, many of whom remain undiagnosed until severe symptoms or acute complications manifest. The need for early identification is particularly urgent among populations with comorbid conditions such as Type 2 diabetes (T2D), chronic kidney disease (CKD), chronic obstructive pulmonary disease (COPD), and coronary artery disease (CAD). Traditional monitoring approaches often overlook these at-risk individuals.
The integration of Reveal for Arrhythmias utilizes advanced algorithms to detect subtle clinical indicators within EHR and other health data, identifying patients who may benefit from earlier evaluation and intervention. Early pilot data suggests that this combined approach enhances the precision and effectiveness of targeting high-risk patients, resulting in more timely and impactful clinical engagement.
From Risk Assessment to Continuous Monitoring
Once Reveal for Arrhythmias identifies individuals at elevated risk, iRhythm’s Zio® ECG service delivers extended ambulatory cardiac monitoring through a wearable device. Capable of up to 14 days of continuous data collection, this technology, powered by an FDA-cleared AI algorithm and paired with review by qualified cardiac technicians, provides clinicians with actionable insights that facilitate accurate and prompt diagnoses.
Supporting Sustainable, Value-Based Care
This joint commercial offering is designed for integration into the workflows of accountable care organizations, integrated health systems, and other entities committed to value-based care. By facilitating earlier detection of arrhythmias, the partnership aims to reduce avoidable hospitalizations and emergency care events, improving both clinical and economic outcomes.
Learn More: Reveal for Arrhythmias
To discover how Lucem Health’s Reveal for Arrhythmias can enable earlier intervention and improve outcomes in your organization, click here to learn more.
Read the Full Press Release
For a comprehensive overview of this partnership and its implications for predictive healthcare, access the full press release here.
Lucem Health and iRhythm remain committed to advancing proactive cardiac care, delivering leading-edge solutions that support patients, providers, and the broader healthcare system.
